InVivo Biosystems (formerly known as NemaMetrix) is a biotechnology company that develops solutions for the genetic modification of simple microscopic living animals for disease research and drug discovery. It explores potential treatments for high-impact disorders such as Alzheimer’s disease, epilepsy, and cancer. The company caters to pharmaceutical, nutraceutical, biotechnology companies, and research institutions.